Answers are grounded in this paper and cite their sources.
The field of microphysiological systems (or organs-on-a-chip) experienced, in the past decade, a surge in publications and efforts towards commercialization. Such systems hold the promise to advance drug discovery, diagnostics, and many other areas. In this review we summarize and analyze the current status of the field, describe the commercial advances and discuss standing challenges and the commercial outlook of the field.
No takes yet. Share an insight, caveat, or question.
Ribas et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: